From consensus statements to clinical practice- PSOGI consensus recommendations clarifying optimal management of peritoneal malignancy
European Journal of Surgical Oncology · 2027-01 · 53 (1) · 112341
DOI: 10.1016/j.ejso.2026.112341 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2027-01. Verfasst von Aditi Bhatt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India. Electronic address: aditimodi31@gmail.com. Die Arbeit nennt 110 Literaturangaben.
Abstract (Originalsprache)
The peritoneal surface oncology group international (PSOGI) was founded by a group of surgeons who defined and pioneered the definitive treatment of peritoneal malignancies (PM). Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) were introduced in the 1980s, and subsequently refined and shown to be reproducible. This combined treatment changed the outlook of many PM from incurable end-stage conditions to treatable diseases with a possibility of cure and/or long term-survival. In the last 25 years, through various consensuses, PSOGI has worked to standardize CRS, establish treatment pathways for PM, transform peritoneal surface oncology from a surgical to a multidisciplinary specialty and promote clinical and translational research on PM. This manuscript summarizes the main recommendations of the PSOGI consensuses conducted in the past two decades, discussing their clinical utility and application in current clinical practice. Adoption of these recommendations in routine care is essential both for optimizing current treatment and its outcomes and facilitating future research.
Autor:innen und Institutionen
- Department of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India. Electronic address: aditimodi31@gmail.com.
- Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Pathology, Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK.
- Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands; GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands.
- Peritoneal Malignancy Unit, Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK.
- Dept of Surgical Oncology, MD Anderson Cancer Centre, Madrid, Spain.
Zitieren
APA
Bhatt, A., Kusamura, S., Carr, N. J., Deraco, M., Lahaye, M. J., Moran, B. J., Gonzalez Moreno, S., Villeneuve, L., Sugarbaker, P. H., & Glehen, O. (2027). From consensus statements to clinical practice- PSOGI consensus recommendations clarifying optimal management of peritoneal malignancy. European Journal of Surgical Oncology, 53(1), 112341. https://doi.org/10.1016/j.ejso.2026.112341
Vancouver
Bhatt A, Kusamura S, Carr NJ, Deraco M, Lahaye MJ, Moran BJ, et al. From consensus statements to clinical practice- PSOGI consensus recommendations clarifying optimal management of peritoneal malignancy. European Journal of Surgical Oncology. 2027;53(1):112341. doi:10.1016/j.ejso.2026.112341
BibTeX
@article{Bhatt2027,
author = {Bhatt, Aditi and Kusamura, Shigeki and Carr, Norman J and Deraco, Marcello and Lahaye, Max J and Moran, Brendan J and Gonzalez Moreno, Santiago and Villeneuve, Laurent and Sugarbaker, Paul H and Glehen, Olivier},
title = {From consensus statements to clinical practice- PSOGI consensus recommendations clarifying optimal management of peritoneal malignancy},
journal = {European Journal of Surgical Oncology},
year = {2027},
volume = {53},
number = {1},
pages = {112341},
doi = {10.1016/j.ejso.2026.112341}
}
EUVIMED